Abstract:Objective: To study the pharmacokinetics of a single dose of piperacillin/sulbactam (4:1) injection in healthy volunteers. Methods: Ten healthy volunteers were selected to receive a single dose of piperacillin/sulbactam (2000mg/500mg) injection or piperacillin (2000mg) alone or sulbactam (500mg) alone in an open randomized cross-over study. The concentrations of piperacillin and sulbactam in serum and urine were determined respectively by two different high-performance liquid chromatography (HPLC) methods. Results: The concentration-time curves of piperacillin and sulbactam were best fitted by an open two-compartment model. The pharmacokinetic parameters were as follows: cmax of piperacillin alone and in compound at the end of infusion were (124.40±20.19) mg/L and (138.70±25.53) mg/L respectively, AUC0-∞ were (129.23 ± 32.91) mg·h/L and (155.81·58.52) mg·h/L respectively, t1/2 were (0.80 ± 0.16)h and (0.88 ± 0.39)h respectively. The cmax of sulbactam alone and in compound preparation at the end of infusion were (29. 25 ± 4.99) mg/L and (44.37 ± 6.48) mg/L respectively, AUC0-∞ were (27.98 ± 4.83) mg±h/L and (42.63 ± 5.65) mg•h/L respectively, t 1/2 were (1.03 ± 0.24)h and (1.02 ± 0.15)h respectively. Urinary recovery rates of piperacillin alone and in compound between 0 to 12h were (55.4 ± 22.0)% and (43.6±12.3)% respectively. Urinary recovery rates of sulbactam alone and in compound preparation between 0 to 12 h were (51.8±25.6)% and (41.5±19.4)% respectively. Conclusions: All volunteers were well tolerated with the three preparations by iv infusion in 30 min. Sulbactam had no interaction on the disposition of piperacillin, but piperacillin had significant influence on the disposition of sulbactam. The urinary recovery rates of piperacillin and sulbactam were significantly lower in compound preparation than in single one, which means piperacillin and sulbactam may compete the same urinary elimination sites.

Pharmacokinetic study on piperacillin and sulbactam (4:1) injection in healthy volunteers